SCHEMBL6320733

SCHEMBL6320733

CNC(=O)c1cccc(-c2cccc3c2CC(=O)N3)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 2/20 0.65
BRD4 O60885 5/20 0.62
CREBBP Q92793 5/20 0.62
ABL1 P00519 1/20 0.47
PIP4K2A P48426 1/20 0.46
PIP4K2B P78356 1/20 0.46
TAF1 P21675 1/20 0.46
DHPS P49366 1/20 0.46
PDK2 Q15119 1/20 0.44
LRRK2 Q5S007 1/20 0.43
CECR2 Q9BXF3 1/20 0.43
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
CDK8 P49336 1/20 0.42
TDP2 O95551 1/20 0.42
UCHL1 P09936 1/20 0.42
CCNB2 O95067 1/20 0.42
CDK1 P06493 1/20 0.42
CCNB1 P14635 1/20 0.42
MDH2 P40926 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6320773 0.84 TDP2 (0.55) CRBNBRD4CREBBPABL1PIP4K2A
SCHEMBL17680966 0.80 CREBBP (0.68) CRBNBRD4CREBBPTAF1PDK2
SCHEMBL23175435 0.79 CRBN (1.00) CRBNBRD4CREBBPPDK2HDAC8
SCHEMBL29899574 0.79 CRBN (1.00) CRBNBRD4CREBBPPDK2HDAC8
SCHEMBL17680816 0.77 CREBBP (1.00) BRD4CREBBP
SCHEMBL6328529 0.76 BRD4 (0.54) BRD4CREBBPABL1PIP4K2APIP4K2B
SCHEMBL6320660 0.75 ABL1 (0.45) BRD4CREBBPABL1PIP4K2APIP4K2B
SCHEMBL5843496 0.75 JAK2 (0.51) BRD4CREBBPABL1PIP4K2APIP4K2B
SCHEMBL155873 0.74 GSK3B (0.50) BRD4CREBBPABL1PIP4K2APIP4K2B
SCHEMBL6319680 0.74 PGR (0.58) ABL1PIP4K2APIP4K2BTDP2CCNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6861418-B2 4-aryl substituted indolinones SUGEN, INC. (US) 2005-03-01 US disclosed
US-20040157909-A1 4-Aryl substituted indolinones SUGEN, INC. 2004-08-12 US disclosed
US-6677368-B2 4-aryl substituted indolinones SUGEN, INC. 2004-01-13 US disclosed
US-20030069297-A1 4-aryl substituted indolinones SUGEN, INC. 2003-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030069297-A1 4-aryl substituted indolinones CDK5, CAMK4, TNK2 CRBN 591/4885BRD4 180/4885CREBBP 174/4885
US-20040157909-A1 4-Aryl substituted indolinones CDK5, CAMK4, TNK2 CRBN 591/4885BRD4 180/4885CREBBP 174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.